Partnership for the Assessment of Risks from Chemicals (PARC) in brief
- A 7-year partnership under Horizon Europe, the EU’s 2021-2027 framework programme for the funding of research and innovation.
- 200 partners in 28 countries and at EU level, national agencies and research organisations working in the areas of the environment or public health, the European Chemical Agency (ECHA), the European Food Safety Authority (EFSA) and the European Environment Agency (EEA)
- A budget of 400 million euros, 50% funded by the European Union and 50% by Member States
Submitted by ANSES and its French and European partners in response to a Horizon Europe call for projects in September 2021, the PARC project received a favourable assessment by the European Commission in January 2022 and has started on the 1st of May 2022.
The Agency, which will be responsible for the scientific and administrative coordination of the partnership, will also participate in cross-cutting activities and scientific production.
One ambition: to move towards a new generation of chemical risk assessment methods
The European Partnership for the Assessment of Risks from Chemicals aims to advance research, share knowledge and improve skills in chemical risk assessment. By doing so, it will help support the European Union's Chemicals Strategy for Sustainability, paving the way for the "zero pollution" ambition announced in the European Green Deal.
PARC represents a campaign of unprecedented scale, since it brings together about 200 French and European players, involving national and European health and safety agencies as well as research organisations. The partnership encompasses all aspects of chemical risk assessment, aiming in particular to: better anticipate emerging risks, better account for combined risks, and underpin the concrete implementation of new orientations in European public policies to safeguard health and the environment in response to important issues for health, the ecology and citizens' expectations.
The partnership will build on work undertaken as part of the European Joint Programme on human biomonitoring, HBM4EU (Human Biomonitoring for Europe), which will come to an end in the summer of 2022, and will broaden the scope of its of interests specifically to the assessment of environmental risks.
- Develop the scientific skills needed to address current and future challenges in chemical safety
- Provide new data, methods and innovative tools to those responsible for assessing and managing the risks of chemical exposure
- Strengthen the networks which bring together actors specialised in the different scientific fields contributing to risk assessment
Main results expected:
- Establishment of a permanent interdisciplinary network on a European scale to identify and prioritise conceptual, scientific and technical advances and needs in terms of research and innovation
- Development of joint research and innovation activities reflecting the defined priorities
- Strengthening of existing capabilities for research and innovation and the creation of new cross-disciplinary platforms in Europe
First steps of the partnership:
- Continue work on human biomonitoring of chemicals, with the launch of European studies in both the general population and in occupational settings, and the drafting of a review of the current state of the art in chemical monitoring in order to set up new schemes or broaden the scope of substances monitored in existing schemes, and to innovate with regard to the analytical methods used.
- Contribute to data generation to meet the regulatory needs and to the development of new methodological approaches to assess effects on humans or on target organisms in the environment.
- Develop computer models and data analysis methods for studying the effects of mixtures and combined exposure.
- Contribute to making data and models accessible and reusable for research and risk assessment purposes (i.e. that meet the FAIR principles: Findable – Accessible – Interoperable – Reusable), as part of an "Open Science" approach.
- Develop the new concepts and tools needed to implement the EU Chemicals Strategy for Sustainability: the chemical synthesis of new compounds or materials without risks to health and the environment, the ability to detect substances that are hazardous to health or the environment, or the provision of modelling tools.
The research strategy and work programme will ensure that an open and transparent dialogue between scientific and regulatory bodies is promoted, involving all stakeholders.
PARC Stakeholder Forum - Open Call for Participation
PARC offers interested European stakeholders the opportunity to participate and actively engage in the Stakeholder Forum (SF) of the partnership. The PARC Stakeholder Forum facilitates interaction, i.e. regular communication, targeted information and continuous exchange on PARC`s process and current developments in chemical risk assessment of human health and the environment at European level. The PARC Stakeholder Forum will hold a maximum of 15 members. In the PARC Stakeholder Forum, it is of importance to have representatives from different parts of society and different sectors in order to bring the opportunity for a combined, cross-sectoral chemical risk assessment, covering production, provision, use and potential impact of chemicals in society, as well as the production and use of knowledge. Thus, if you are a European organisation, who is interested in and affected by risk assessment of chemicals and/or involved in risk communication or familiar with science to public or science to policy interactions - we cordially invite you to respond to this call. Following the open call, the selection process for future stakeholder members will be based on the criteria defined in the call while also ensuring complementarity in expertise and broad coverage of interests and regions. A final list of members to constitute the PARC Stakeholder Forum will be achieved in November 2022. The first online meeting is scheduled for December 2022/early January 2023.
This partnership has received funding from the European Union’s Horizon Europe research and innovation programme under Grant Agreement No 101057014